U.S. Wealth WatcherCelebrating Political Fortunes
HR 9682 · 119th CongressIntroduced

Eliminate hepatitis C nationwide

Banking & Financial
The vote
Worked the bill
$560M
24 groups · their total 2025 lobbying
In the distance
Summary

What the bill does

This bill creates a federal program to eliminate hepatitis C in the United States. It sets up a subscription model where the government buys hepatitis C treatments in bulk from drugmakers and gives them for free to certain groups, including people in prison, uninsured individuals, and those on Medicaid or Indian health programs. The bill also requires a national strategy, an advisory committee, and a public dashboard to track progress.

Why it matters

The stakes

Hepatitis C is a serious liver disease that can be cured with antiviral drugs, but many people cannot afford them. This bill aims to make treatment free for the most affected populations, potentially saving thousands of lives and reducing long-term health costs.

Major public companies this covers
  • Gilead SciencesGILD
  • AbbVieABBV
  • MerckMRK
The debate

What each side says

Supporters
  • The bill would provide free hepatitis C treatment to uninsured people and those in prisons, who often lack access to care.bill
  • By using a subscription model, the government can negotiate lower drug prices and ensure a steady supply of treatments.bill
  • The bill requires a national strategy and public dashboard to track progress, making the effort transparent and accountable.bill
Critics
  • The bill prohibits using other federal drug discount programs for these treatments, which could limit savings for some hospitals and clinics.bill
  • The program may be expensive for taxpayers, as the government would bear the full cost of purchasing treatments for millions of people.report

Each point links to its source. The views are attributed to those sources, not stated as ours.

Follow the money

From this bill outward

The bill

where every tie is measured from
HR 9682Eliminate hepatitis C nationwideBanking & Financial

Who paid lobbyists to work it

Direct tie24 groups · their total 2025 lobbying
GroupIssues2025 lobbying
(all issues)
Has PAC?
MERCK & CO., INC.Named in billHealthBankingForeign$11MMEPAC
GILEAD SCIENCES, INC.Named in billHealthOtherForeign$7.8MGS
ABBVIE INC.Named in billHealthBankingOther$5.6MAPAC
STATE OF LOC NATION GLOBAL PUBLIC BENEFIT CORPORATIONAdvocacyOtherBanking$80MNo PAC
CHAMBER OF COMMERCE OF THE U.S.A.EnergyBankingForeign$70MNo PAC
NATIONAL ASSOCIATION OF REALTORSReal EstateBankingInsurance$54MNAORPAC
BUSINESS ROUNDTABLE INCEnergyBankingHealth$34MNo PAC
META PLATFORMS, INC. AND VARIOUS SUBSIDIARIESTechSports & MediaBanking$26MNo PAC

Election money, in the distance

Background · not tied to this billBanking & Financial PACs -> the members who voted

The background money view appears when a bill has a recorded vote and matching sector PAC data.

Lobbying filings, contributions, and votes are public records shown side by side. The further down the chain, the further the money is from this bill. This page does not assert that money caused any vote.